Pharmaceutical and Medical Device
King & Spalding’s Pharmaceutical & Medical Device practice is consistently recognized as among the best in the nation. Our knowledge of the industry, combined with our broad capabilities and a deep bench of first-chair trial attorneys, allow us to handle any aspect of drug and device litigation, from early case assessment, through discovery, and on to trial and exit strategies.
May 14, 2024
USTR Releases the Results Of Its Four-Year Review Of China Section 301 Tariffs
April 30, 2024
LDT Final Rule: Shifting the LDT Battlefield
March 6, 2024
Ursula Henninger Inducted Into American College of Trial Lawyers
April 18, 2024
King & Spalding Secures Defense Jury Verdict for Johnson & Johnson in Cosmetic Talcum Powder Litigation